Ignite Creation Date:
2024-10-25 @ 7:47 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06636825
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-10-04
Brief Title:
Influence of Caffeine on Psychomotor Vigilance and Carbon Dioxide Tolerance During Graded Hypercapnia
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Influence of Caffeine on Psychomotor Vigilance and Carbon Dioxide Tolerance During Graded Hypercapnia
Status:
COMPLETED
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
C3F
Brief Summary:
The aim of this randomized double-blind placebo-controlled crossover trial is to determine the effects of caffeine vs placebo on psychomotor vigilance and carbon dioxide tolerance during graded hypercapnia
Detailed Description:
Healthy and fit young adults men and women will participate in this study Participants will perform two primary experimental trials on separate days one after consuming 400 mg caffeine and the other after consuming a non-caffeinated placebo During each trial participants will breathe increasing levels of inspired CO2 in a stepwise manner 0 2 4 6 8 CO2 all with 21 oxygen during successive 12-minute stages The endpoints of the graded hypercapnia protocol will be completion of the 8 CO2 stage voluntary subject termination due to discomfort or end-tidal CO2 greater than 70 mmHg The investigators hypothesize that compared to placebo caffeine will lower end tidal and arterialized PCO2 and mitigate CO2-mediated decrements in psychomotor vigilance
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None